{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:39:50Z","timestamp":1792496390070,"version":"4.5.0"},"reference-count":31,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,3,16]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Monoclonal gammopathy is associated with C3 glomerulopathy. Specific treatment of the underlying B-cell clone improves renal survival.<\/jats:p>","DOI":"10.1182\/blood-2016-08-737163","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T22:00:29Z","timestamp":1483999229000},"page":"1437-1447","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":175,"title":["Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy\u2013associated C3 glomerulopathy"],"prefix":"10.1182","volume":"129","author":[{"given":"Sophie","family":"Chauvet","sequence":"first","affiliation":[{"name":"Department of Nephrology, H\u00f4pital Europ\u00e9en Georges Pompidou, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Paris, France;"},{"name":"INSERM Unit\u00e9 Mixte de Recherche 1138, \u201cCompl\u00e9ment et Maladies,\u201d Centre de Recherche des Cordeliers, Paris, France;"},{"name":"Universit\u00e9 Paris Descartes Sorbonne Paris-Cit\u00e9, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Fr\u00e9meaux-Bacchi","sequence":"additional","affiliation":[{"name":"INSERM Unit\u00e9 Mixte de Recherche 1138, \u201cCompl\u00e9ment et Maladies,\u201d Centre de Recherche des Cordeliers, Paris, France;"},{"name":"Department of Immunology, H\u00f4pital Europ\u00e9en Georges Pompidou, AP-HP, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Petitprez","sequence":"additional","affiliation":[{"name":"INSERM Unit\u00e9 Mixte de Recherche 1138, \u201cCancer, Immune Control and Escape,\u201d Centre de Recherche des Cordeliers, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Karras","sequence":"additional","affiliation":[{"name":"Department of Nephrology, H\u00f4pital Europ\u00e9en Georges Pompidou, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Daniel","sequence":"additional","affiliation":[{"name":"Department of Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Burtey","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Centre Hospitalier Universitaire La Conception, Marseille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Choukroun","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Centre Hospitalier Universitaire d\u2019Amiens, Amiens, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahsou","family":"Delmas","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Guerrot","sequence":"additional","affiliation":[{"name":"Department of Nephrology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Fran\u00e7ois","sequence":"additional","affiliation":[{"name":"Department of Pathology, Centre Hospitalier Universitaire de Rouen, Rouen, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moglie","family":"Le Quintrec","sequence":"additional","affiliation":[{"name":"Department of Nephrology H\u00f4pital de Foch, Surennes, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Javaugue","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Centre Hospitalier Universitaire de Poitiers, Poitiers, France;"},{"name":"Centre National de R\u00e9f\u00e9rence maladies rares: amylose AL et autres maladies \u00e0 d\u00e9p\u00f4ts d\u2019immunoglobulines monoclonales, Universit\u00e9 de Poitiers, Poitiers, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ribes","sequence":"additional","affiliation":[{"name":"Department of Nephrology Centre Hospitalier Universitaire de Toulouse, Toulouse, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Vrigneaud","sequence":"additional","affiliation":[{"name":"Department of Nephrology H\u00f4pital de Valenciennes, Valenciennes, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Arnulf","sequence":"additional","affiliation":[{"name":"Department of Immunology and Hematology, H\u00f4pital Saint Louis, AP-HP, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Michel","family":"Goujon","sequence":"additional","affiliation":[{"name":"Centre National de R\u00e9f\u00e9rence maladies rares: amylose AL et autres maladies \u00e0 d\u00e9p\u00f4ts d\u2019immunoglobulines monoclonales, Universit\u00e9 de Poitiers, Poitiers, France;"},{"name":"Department of Pathology, Centre Hospitalier Universitaire de Poitiers, Poitiers, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Ronco","sequence":"additional","affiliation":[{"name":"Department of Nephrology, H\u00f4pital Tenon, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Touchard","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Centre Hospitalier Universitaire de Poitiers, Poitiers, France;"},{"name":"Centre National de R\u00e9f\u00e9rence maladies rares: amylose AL et autres maladies \u00e0 d\u00e9p\u00f4ts d\u2019immunoglobulines monoclonales, Universit\u00e9 de Poitiers, Poitiers, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bridoux","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Centre Hospitalier Universitaire de Poitiers, Poitiers, France;"},{"name":"Centre National de R\u00e9f\u00e9rence maladies rares: amylose AL et autres maladies \u00e0 d\u00e9p\u00f4ts d\u2019immunoglobulines monoclonales, Universit\u00e9 de Poitiers, Poitiers, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"4","key":"2019111905150757400_B1","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ki.2014.408","article-title":"Diagnosis of monoclonal gammopathy of renal significance","volume":"87","author":"Bridoux","year":"2015","journal-title":"Kidney Int"},{"issue":"22","key":"2019111905150757400_B2","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1182\/blood-2013-05-495929","article-title":"How I treat monoclonal gammopathy of renal significance (MGRS)","volume":"122","author":"Fermand","year":"2013","journal-title":"Blood"},{"issue":"8","key":"2019111905150757400_B3","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrneph.2010.85","article-title":"C3 glomerulopathy: a new classification","volume":"6","author":"Fakhouri","year":"2010","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"2019111905150757400_B4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jmg.2006.045328","article-title":"Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome","volume":"44","author":"Servais","year":"2007","journal-title":"J Med Genet"},{"issue":"6","key":"2019111905150757400_B5","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.2013.377","article-title":"C3 glomerulopathy: consensus report","volume":"84","author":"Pickering","year":"2013","journal-title":"Kidney Int"},{"issue":"2","key":"2019111905150757400_B6","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/ki.2013.340","article-title":"Toward a working definition of C3 glomerulopathy by immunofluorescence","volume":"85","author":"Hou","year":"2014","journal-title":"Kidney Int"},{"issue":"4","key":"2019111905150757400_B7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ki.2012.63","article-title":"Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies","volume":"82","author":"Servais","year":"2012","journal-title":"Kidney Int"},{"issue":"5","key":"2019111905150757400_B8","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2215\/CJN.07110810","article-title":"Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement","volume":"6","author":"Sethi","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"2019111905150757400_B9","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1681\/ASN.2005010078","article-title":"Membranoproliferative glomerulonephritis type II (dense deposit disease): an update","volume":"16","author":"Appel","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"14","key":"2019111905150757400_B10","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.molimm.2011.04.005","article-title":"Dense deposit disease","volume":"48","author":"Smith","year":"2011","journal-title":"Mol Immunol"},{"issue":"5","key":"2019111905150757400_B11","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1053\/j.ajkd.2010.06.021","article-title":"Dense deposit disease associated with monoclonal gammopathy of undetermined significance","volume":"56","author":"Sethi","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"2019111905150757400_B12","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.2215\/CJN.06180710","article-title":"Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association?","volume":"6","author":"Bridoux","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"2019111905150757400_B13","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1053\/j.ajkd.2013.02.370","article-title":"C3 glomerulonephritis associated with monoclonal gammopathy: a case series","volume":"62","author":"Zand","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"2019111905150757400_B14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"issue":"2 Suppl 1","key":"2019111905150757400_B15","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"2019111905150757400_B16","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","author":"International Myeloma Working Group","year":"2003","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111905150757400_B17","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"issue":"22","key":"2019111905150757400_B18","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood-2012-07-445304","article-title":"Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant","volume":"120","author":"Leung","year":"2012","journal-title":"Blood"},{"issue":"8","key":"2019111905150757400_B19","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/ki.2012.280","article-title":"The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient","volume":"82","author":"Radhakrishnan","year":"2012","journal-title":"Kidney Int"},{"issue":"9","key":"2019111905150757400_B20","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma","volume":"20","author":"Durie","year":"2006","journal-title":"Leukemia"},{"issue":"36","key":"2019111905150757400_B21","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","article-title":"New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes","volume":"30","author":"Palladini","year":"2012","journal-title":"J Clin Oncol"},{"issue":"1-2","key":"2019111905150757400_B22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jim.2010.12.020","article-title":"Alternative complement pathway assessment in patients with atypical HUS","volume":"365","author":"Roumenina","year":"2011","journal-title":"J Immunol Methods"},{"issue":"7","key":"2019111905150757400_B23","first-page":"811","article-title":"Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation","volume":"9","author":"Fr\u00e9meaux-Bacchi","year":"1994","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"2019111905150757400_B24","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2215\/CJN.12901211","article-title":"Eculizumab for dense deposit disease and C3 glomerulonephritis","volume":"7","author":"Bomback","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"2019111905150757400_B25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/MNH.0b013e32835da24c","article-title":"Treatment options for C3 glomerulopathy","volume":"22","author":"Nester","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"12","key":"2019111905150757400_B26","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMc1111953","article-title":"Eculizumab for the treatment of dense-deposit disease","volume":"366","author":"Vivarelli","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111905150757400_B27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5414\/CN107945","article-title":"Remission of C3 glomerulopathy with rituximab as only immunosuppressive therapy","volume":"83","author":"Giaime","year":"2015","journal-title":"Clin Nephrol"},{"issue":"5","key":"2019111905150757400_B28","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/ki.2015.227","article-title":"Effectiveness of mycophenolate mofetil in C3 glomerulonephritis","volume":"88","author":"Rabasco","year":"2015","journal-title":"Kidney Int"},{"issue":"11","key":"2019111905150757400_B29","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.4049\/jimmunol.1402770","article-title":"Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases","volume":"194","author":"Blanc","year":"2015","journal-title":"J Immunol"},{"issue":"8","key":"2019111905150757400_B30","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.4049\/jimmunol.163.8.4590","article-title":"Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H","volume":"163","author":"Jokiranta","year":"1999","journal-title":"J Immunol"},{"issue":"11","key":"2019111905150757400_B31","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.2215\/CJN.01820214","article-title":"Defining the complement biomarker profile of C3 glomerulopathy","volume":"9","author":"Zhang","year":"2014","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/11\/1437\/1398696\/blood737163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/11\/1437\/1398696\/blood737163.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T13:12:45Z","timestamp":1692623565000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/11\/1437\/35927\/Treatment-of-Bcell-disorder-improves-renal-outcome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,16]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,3,16]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-08-737163","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,16]]}}}